Education
About Us
Working with TipRanks
Follow Us
InDex Pharmaceuticals Holding AB (DE:1NP1)
FRANKFURT:1NP1
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 8.80M | kr 100.00K | kr 97.50M | kr 0.00 | kr 0.00 |
| Gross Profit | kr -12.70M | kr -41.60M | kr 93.35M | kr -1.07M | kr -1.25M |
| Operating Income | kr -782.10M | kr -110.80M | kr -107.37M | kr -151.11M | kr -115.63M |
| EBITDA | kr -743.60M | kr -225.90M | kr -93.82M | kr -99.15M | kr -101.66M |
| Net Income | kr -756.90M | kr -228.00M | kr -95.27M | kr -100.33M | kr -103.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 540.20M | kr 865.10M | kr 294.27M | kr 344.93M | kr 428.45M |
| Total Assets | kr 3.40B | kr 4.22B | kr 299.39M | kr 351.34M | kr 445.20M |
| Total Debt | kr 3.70M | kr 800.00K | kr 2.30M | kr 3.25M | kr 1.28M |
| Net Debt | kr -536.50M | kr -864.30M | kr -291.97M | kr -341.68M | kr -427.17M |
| Total Liabilities | kr 20.30M | kr 25.30M | kr 60.50M | kr 17.38M | kr 11.16M |
| Stockholders' Equity | kr 3.38B | kr 4.20B | kr 238.88M | kr 333.96M | kr 434.04M |
| Cash Flow | |||||
| Free Cash Flow | kr 0.00 | kr -17.00M | kr -37.98M | kr -129.44M | kr -124.06M |
| Operating Cash Flow | kr -28.10M | kr -17.00M | kr -37.98M | kr -129.44M | kr -124.06M |
| Investing Cash Flow | kr -109.50M | kr -19.80M | kr -625.20M | kr 0.00 | kr 0.00 |
| Financing Cash Flow | kr -195.50M | kr 571.90M | kr 634.70M | kr -818.00K | kr 486.39M |